Exploring the mitochondrial-derived peptide at the forefront of metabolic and exercise science research.
MOTS-C (Mitochondrial Open Reading Frame of the Twelve S rRNA Type-C) is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded by the 12S rRNA gene of mitochondrial DNA. First discovered in 2015 by Dr. Changhan David Lee and colleagues at the University of Southern California, MOTS-C represented a groundbreaking finding in mitochondrial biology: a functional peptide encoded within a region of the mitochondrial genome previously thought to serve only structural roles in ribosomal RNA.
Unlike most peptides studied in research settings, MOTS-C originates from the mitochondrial genome rather than nuclear DNA. This distinction has made it a subject of intense scientific interest, as it suggests mitochondria play a far more active role in systemic signaling than previously understood. MOTS-C is detectable in circulation and in various tissues, supporting the hypothesis that it functions as a mitochondrial-derived signaling molecule capable of influencing whole-body metabolism.
The discovery of MOTS-C emerged from a systematic search for biologically active peptides encoded within the mitochondrial genome. Dr. Lee's team at USC identified the peptide through computational analysis of mitochondrial open reading frames and subsequently confirmed its endogenous expression and metabolic activity in preclinical models. The initial 2015 publication demonstrated that MOTS-C administration in mouse models influenced metabolic parameters including glucose regulation and fatty acid oxidation.
Since its discovery, MOTS-C research has expanded rapidly across multiple laboratories worldwide. Studies in rodent models have investigated the peptide's effects on diet-induced obesity, age-related metabolic decline, and exercise physiology. A particularly notable finding is that endogenous MOTS-C levels appear to increase during physical exercise and decline with age, leading researchers to describe it as an "exercise mimetic" peptide. This connection between a mitochondrial-derived signal and physical activity has opened new avenues of investigation into how mitochondria communicate metabolic status to distant tissues.
MOTS-C is a 16-amino-acid peptide with the sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg. It has a molecular weight of approximately 2,174 Da. The peptide is translated from a short open reading frame within the 12S rRNA gene located on mitochondrial DNA, making it one of several known mitochondrial-derived peptides alongside humanin and SHLPs (Small Humanin-Like Peptides).
The relatively small size of MOTS-C contributes to its stability and detectability in plasma. It is water-soluble and is commercially available as a lyophilized (freeze-dried) powder at 40mg per vial, suitable for reconstitution with bacteriostatic water or sterile saline for laboratory use.
MOTS-C research has identified the AMPK (5' AMP-activated protein kinase) pathway as a primary mediator of its metabolic effects. AMPK is a master regulator of cellular energy homeostasis, and its activation by MOTS-C appears to drive downstream effects on glucose uptake, fatty acid metabolism, and mitochondrial function. In preclinical models, MOTS-C treatment has been associated with increased AMPK phosphorylation in skeletal muscle and other metabolically active tissues.
Beyond AMPK activation, research suggests MOTS-C may influence the folate-methionine cycle, altering cellular one-carbon metabolism and purine biosynthesis. This metabolic reprogramming is thought to contribute to the peptide's effects on insulin sensitivity and cellular energy balance. Studies have also observed that MOTS-C can translocate to the nucleus during metabolic stress, where it may interact with transcription factors involved in antioxidant response pathways, further connecting mitochondrial signaling to nuclear gene regulation.
MOTS-C is utilized across several active research domains. Metabolic studies investigate its effects on insulin sensitivity, glucose homeostasis, and lipid metabolism in diet-induced obesity models. Exercise physiology research examines the peptide's role as a potential exercise mimetic, exploring whether it can replicate some of the metabolic benefits associated with physical activity. Age-related research focuses on the observation that endogenous MOTS-C levels decline with aging, and whether exogenous administration can influence age-associated metabolic changes.
Additional applications include cellular energy metabolism studies, AMPK signaling pathway research, and investigations into mitochondrial-nuclear communication. The peptide's unique origin in the mitochondrial genome also makes it valuable for evolutionary biology research examining the conservation of mitochondrial-derived peptides across species.
Lyophilized MOTS-C should be stored at -20°C for long-term preservation. Unopened vials stored under these conditions maintain stability for extended periods. Once reconstituted with bacteriostatic water or sterile saline, the solution should be refrigerated at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles, as this can degrade peptide integrity. Always handle with appropriate laboratory gloves and use sterile technique during reconstitution to prevent contamination.
This product is sold exclusively for laboratory and scientific research purposes. It is not intended for human or veterinary use, diagnostic purposes, or therapeutic applications. All research must comply with applicable laws and institutional guidelines. By purchasing, you confirm you are a qualified researcher. Please review our full legal disclaimer.